Firststring Research Inc
Xequel Bio is a clinical stage biopharmaceutical company based in Fort Worth, Texas and Mount Pleasant, South Carolina. Led by a proven leadership team, Xequel Bio is dedicated to pioneering the science of possibilities by developing innovative drugs that revolutionize the body's response to injury. Their proprietary alpha-connexin carboxyl-terminus 1 (aCT1) peptide technology platform has shown promising results in preclinical and clinical research, with applications in Dermatology, Ophthalmology, and Pulmonology.
With a focus on addressing unmet medical needs, Xequel Bio is committed to developing treatments that promote healing and tissue regeneration. Their product portfolio includes Granexin Gel for dermatology and wound healing, iNexin Ophthalmic Solution for corneal and retinal diseases, and Aerosolized aCT1 for acute pulmonary injuries. By combining leadership, innovation, and technology, Xequel Bio aims to make a significant impact on the lives of doctors and patients alike.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.